HIT Trademark

Trademark Overview


On Monday, May 17, 2004, a trademark application was filed for HIT with the United States Patent and Trademark Office. The USPTO has given the HIT trademark a serial number of 78420082. The federal status of this trademark filing is ABANDONED - EXPRESS as of Thursday, July 7, 2005. This trademark is owned by Jagotec AG. The HIT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations adapted for the topical, injectable, and intravenous treatment of the following, cancer, increasing activity of macrophages; reduction of swelling in the brain of person suffering brain trauma; herpes, canker sores, shingles; renal failure, cardiac insufficiency, hypertension, oedema; infection, acne, mononucleosis; transplants; inflammation, elimination of tumor breakdown material (toxins and debris), decreasing side effects, relief of pain; detoxification, brochodilation; vascular ischemia; HIV(AIDS); diabetes; post-menopause; prevention of topical infection; reduction of swelling; hypertension, cardiac insufficiency; prostaglandin synthesis inhibition; enhancement of oxygenation of tissue by perfusion fluid bathing of the tissue (for transplantation purposes); sub-retinal neovascularization and as an adjunct to the treatment of cancer to prevent metastasis; arthritis or pannus; cancer tumors; inhibiting angiogenesis; controlling angiogenesis; regressing a...
hit

General Information


Serial Number78420082
Word MarkHIT
Filing DateMonday, May 17, 2004
Status601 - ABANDONED - EXPRESS
Status DateThursday, July 7, 2005
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations adapted for the topical, injectable, and intravenous treatment of the following, cancer, increasing activity of macrophages; reduction of swelling in the brain of person suffering brain trauma; herpes, canker sores, shingles; renal failure, cardiac insufficiency, hypertension, oedema; infection, acne, mononucleosis; transplants; inflammation, elimination of tumor breakdown material (toxins and debris), decreasing side effects, relief of pain; detoxification, brochodilation; vascular ischemia; HIV(AIDS); diabetes; post-menopause; prevention of topical infection; reduction of swelling; hypertension, cardiac insufficiency; prostaglandin synthesis inhibition; enhancement of oxygenation of tissue by perfusion fluid bathing of the tissue (for transplantation purposes); sub-retinal neovascularization and as an adjunct to the treatment of cancer to prevent metastasis; arthritis or pannus; cancer tumors; inhibiting angiogenesis; controlling angiogenesis; regressing angiogenesis; basal cell carcinoma; actinic keratoses; liver spots; squamous cell tumors; metastatic cancer of the breast to the skin; primary and metastatic melanoma of the skin; malignancies and/or tumor of the skin; genital warts (condyloma acuminata); cervical cancer; human papilloma virus (HVP); psoriasis, corns on the feet; and hair loss on the heads of pregnant women; topical treatment of pain in the skin and or exposed tissue; clearing of atherosclerosis; prevention of arterial restenosis after balloon angioplasty; macrophage infiltration; pharmaceutical preparations comprising hyaluronan; licensing of intellectual property technology and research and developing for others, regarding pharmaceutical preparations, including pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of medical conditions and disease in humans

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 24, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJagotec AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMuttenz 4132
CH

Trademark Events


Event DateEvent Description
Friday, July 8, 2005ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Thursday, July 7, 2005ABANDONMENT - EXPRESS MAILED
Tuesday, July 5, 2005TEAS EXPRESS ABANDONMENT RECEIVED
Monday, January 3, 2005NON-FINAL ACTION MAILED
Monday, January 3, 2005NON-FINAL ACTION WRITTEN
Wednesday, December 15, 2004ASSIGNED TO EXAMINER
Monday, May 24, 2004NEW APPLICATION ENTERED IN TRAM